HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cindy L Linn Selected Research

PNU-282987

1/2021Stimulation of α7 nAChR leads to regeneration of damaged neurons in adult mammalian retinal disease models.
12/2015Retinal ganglion cell neuroprotection induced by activation of alpha7 nicotinic acetylcholine receptors.
2/2014A nicotinic acetylcholine receptor agonist prevents loss of retinal ganglion cells in a glaucoma model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cindy L Linn Research Topics

Disease

5Glaucoma
01/2021 - 05/2004
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2021 - 01/2019
1Retinal Diseases
01/2021
1Cicatrix (Scar)
12/2015

Drug/Important Bio-Agent (IBA)

3PNU-282987IBA
01/2021 - 02/2014
2Retinaldehyde (Retinal)IBA
01/2021 - 01/2019
2Neuroprotective AgentsIBA
12/2015 - 02/2014
1Nerve Growth Factors (Neurotrophins)IBA
01/2016
1Ophthalmic Solutions (Eye Drops)IBA
12/2015
1Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
02/2014
1N-Methylaspartate (NMDA)IBA
05/2004
1Glutamic Acid (Glutamate)FDA Link
05/2004

Therapy/Procedure

1Therapeutics
01/2016
1Intravitreal Injections
02/2014